David P. Fairlie

Q: What Schools Are Affiliated With David P. Fairlie

David P. Fairlie is affiliated with the following schools: University of California, Berkeley, University of Queensland, University of New South Wales, Stanford University

David P. Fairlie's AcademicInfluence.com Rankings

David P. Fairlie

Engineering

#3731

World Rank

#4847

Historical Rank

Electrical Engineering

#865

World Rank

#936

Historical Rank

engineering Degrees

David P. Fairlie

Computer Science

#4776

World Rank

#5041

Historical Rank

Computational Linguistics

#528

World Rank

#536

Historical Rank

Machine Learning

#1048

World Rank

#1064

Historical Rank

Artificial Intelligence

#1278

World Rank

#1302

Historical Rank

computer-science Degrees

Download Badge

Engineering
Computer Science

David P. Fairlie's Degrees

PhD Computer Science Stanford University
Masters Electrical Engineering University of California, Berkeley

Similar Degrees You Can Earn

Best Online PhD of Computer Science (Doctorates) 2026

Why Is David P. Fairlie Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David P. Fairlie's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Future of Peptide‐based Drugs (2013) (1348)
MR1 presents microbial vitamin B metabolites to MAIT cells (2012) (1051)
Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. (1999) (708)
Protease inhibitors: current status and future prospects. (2000) (694)
T-cell activation by transitory neo-antigens derived from distinct microbial pathways (2014) (610)
Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. (2008) (548)
Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? (1998) (475)
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells (2013) (463)
Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* (1999) (459)
Histone deacetylases as regulators of inflammation and immunity. (2011) (436)
Function, structure and therapeutic potential of complement C5a receptors (2007) (374)
Proteases universally recognize beta strands in their active sites. (2005) (361)
Structure, function and pathophysiology of protease activated receptors. (2011) (322)
Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors* (2001) (277)
Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers (2015) (275)
Inflammatory lipid mediators in adipocyte function and obesity (2010) (268)
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. (2000) (268)
Constraining cyclic peptides to mimic protein structure motifs. (2014) (262)
Protease inhibitors in the clinic. (2005) (255)
Recognition of vitamin B metabolites by mucosal-associated invariant T cells (2013) (252)
A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage (2016) (249)
Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. (1999) (248)
Single turn peptide alpha helices with exceptional stability in water. (2005) (237)
A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells (2014) (216)
Orally Absorbed Cyclic Peptides. (2017) (209)
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. (2003) (208)
Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18–dependent activation (2016) (202)
New insights into growth hormone action. (2006) (199)
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles (2019) (195)
Histone deacetylase inhibitors in inflammatory disease. (2009) (195)
Amyloid peptides and proteins in review. (2007) (191)
Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death (2007) (186)
Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll‐like receptor 4 agonist LPS (2010) (186)
Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals (2016) (183)
Beta-strand mimetics. (2004) (176)
Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. (2005) (169)
Human blood MAIT cell subsets defined using MR1 tetramers (2018) (166)
Towards protein surface mimetics. (1998) (163)
Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition. (2016) (157)
Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease (2014) (156)
A new paradigm for protein kinase inhibition: blocking phosphorylation without directly targeting ATP binding. (2007) (156)
Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency (2010) (150)
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells (2017) (150)
MAIT cells protect against pulmonary Legionella longbeachae infection (2018) (149)
Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche. (2014) (145)
Update 1 of: Proteases universally recognize beta strands in their active sites. (2010) (143)
Macrocyclic Peptidomimetics Forcing Peptides into Bioactive Conformations (1995) (137)
Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? (1998) (133)
Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. (2009) (132)
Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria (2006) (131)
Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. (2002) (127)
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate (1999) (127)
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats (2010) (125)
Comparative α-helicity of cyclic pentapeptides in water. (2014) (124)
Targeting HIV-1 protease: a test of drug-design methodologies. (1995) (124)
A Potent Human C5a Receptor Antagonist Protects against Disease Pathology in a Rat Model of Inflammatory Bowel Disease 1 (2003) (122)
C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling (2013) (119)
Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity (2002) (118)
Conformational selection of inhibitors and substrates by proteolytic enzymes: implications for drug design and polypeptide processing. (2000) (118)
Homogeneous Catalysis - Conversion of 4-Pentenals to Cyclopentanones by Efficient Rhodium-Catalyzed Hydroacylation (1988) (117)
The intracellular pathway for the presentation of vitamin B–related antigens by the antigen-presenting molecule MR1 (2016) (117)
Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. (2002) (116)
Proteolysis of human hemoglobin by schistosome cathepsin D. (2001) (116)
Flavones are inhibitors of HIV-1 proteinase. (1992) (115)
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc (2020) (115)
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats1 (2000) (113)
Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease* (2004) (113)
Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites (2015) (112)
Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients (2014) (109)
Improving on nature: making a cyclic heptapeptide orally bioavailable. (2014) (109)
Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues (2008) (108)
Anti-malarial effect of histone deacetylation inhibitors and mammalian tumour cytodifferentiating agents. (2000) (107)
Update 1 of: Beta-strand mimetics. (2010) (106)
Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells* (2015) (106)
Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. (2004) (105)
Catalyst-free N-arylation using unactivated fluorobenzenes. (2012) (99)
Lysine acetylation in obesity, diabetes and metabolic disease (2012) (97)
Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells (2017) (95)
An antagonist of human protease activated receptor‐2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen‐induced arthritis in rats (2012) (94)
Pharmacological characterization of antagonists of the C5a receptor (1999) (93)
Novel agonists and antagonists for human protease activated receptor 2. (2010) (92)
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity (1999) (92)
crystal Structure and Electrospray Ionization Mass Spectrometry, Electron Paramagnetic Resonance, and Magnetic Susceptibility Study of [Cu2(ascidH2)(1,2-.mu.-CO3)(H2O)2].cntdot.2H2O, the Bis(copper(II)) Complex of Ascidiacyclamide (ascidH4), a Cyclic Peptide Isolated from the Ascidian Lissoclinum pa (1994) (91)
Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis (2012) (90)
Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism (2013) (89)
Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. (2004) (89)
Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases (2016) (88)
Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats. (2004) (88)
Homology model of the dengue 2 virus NS3 protease: putative interactions with both substrate and NS2B cofactor. (1999) (88)
In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. (2009) (87)
A 195Pt and 15N N.M.R. study of the anticancer drug, cis-diammine-dichloroplatinum(II), and its hydrolysis and oligomerization products (1981) (85)
Homogeneous catalysis. Mechanism of catalytic hydroacylation: the conversion of 4-pentenals to cyclopentanones (1988) (83)
Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion. (2003) (82)
X-ray absorption spectroscopy of cadmium phytochelatin and model systems. (1999) (81)
Comparative anti‐inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury (2004) (80)
Targeting histone deacetylase inhibitors for anti-malarial therapy. (2009) (80)
Histone Deacetylase 7 Promotes Toll-like Receptor 4-dependent Proinflammatory Gene Expression in Macrophages* (2013) (80)
Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a. (1998) (79)
D‐Tyrosine as a Chiral Precusor to Potent Inhibitors of Human Nonpancreatic Secretory Phospholipase A2 (IIa) with Antiinflammatory Activity (2003) (78)
West Nile Virus NS2B/NS3 protease as an antiviral target. (2008) (78)
Antimalarial Activity of the Anticancer Histone Deacetylase Inhibitor SB939 (2012) (76)
MAIT cells promote tumor initiation, growth and metastases via tumor MR1. (2019) (75)
Insights to Substrate Binding and Processing by West Nile Virus NS3 Protease through Combined Modeling, Protease Mutagenesis, and Kinetic Studies* (2006) (75)
Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites (2015) (74)
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity. (2008) (74)
Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth (2016) (72)
Alpha-turn mimetics: short peptide alpha-helices composed of cyclic metallopentapeptide modules. (2004) (70)
Current status of short synthetic peptides as vaccines. (2006) (70)
A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1 (2019) (70)
Tumor cell‐specific cytotoxicity by targeting cell cycle checkpoints (2003) (69)
Update 1 of: Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. (2010) (69)
Inflammatory Responses Induced by Lipopolysaccharide Are Amplified in Primary Human Monocytes but Suppressed in Macrophages by Complement Protein C5a (2013) (69)
HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation (2012) (69)
Stapling peptides using cysteine crosslinking (2016) (69)
Effects of a new C5a receptor antagonist on C5a‐ and endotoxin‐ induced neutropenia in the rat (1999) (69)
Nonpeptidic ligands for peptide-activated G protein-coupled receptors. (2007) (68)
Toward drugs for protease-activated receptor 2 (PAR2). (2013) (68)
Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist. (2000) (67)
Recipient mucosal-associated invariant T cells control GVHD within the colon (2018) (67)
Agonists and antagonists of protease activated receptors (PARs). (2006) (67)
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma (2018) (67)
Is Oxidative Damage by β-Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine α-Carbon to Methionine Sulfur within β-Sheets? (2000) (66)
Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases. (2001) (62)
Comparative Gene Expression Profiling of P. falciparum Malaria Parasites Exposed to Three Different Histone Deacetylase Inhibitors (2012) (62)
Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus. (2006) (62)
Homogeneous catalysis: catalytic intramolecular conversion of 1,4-dialdehydes to .gamma.-lactones (1990) (62)
Histone deacetylase inhibitors and periodontal bone loss. (2011) (62)
Towards histone deacetylase inhibitors as new antimalarial drugs. (2012) (61)
Characterization of Copper Interactions with Alzheimer Amyloid β Peptides (2000) (60)
Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity. (2008) (59)
An overview on the identification of MAIT cell antigens (2018) (58)
Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis. (2015) (58)
Synthesis, stability, antiviral activity, and protease-bound structures of substrate-mimicking constrained macrocyclic inhibitors of HIV-1 protease. (2000) (57)
Conformational homogeneity in molecular recognition by proteolytic enzymes (1999) (57)
Species Dependence for Binding of Small Molecule Agonist and Antagonists to the C5a Receptor on Polymorphonuclear Leukocytes (2001) (56)
The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding* (2006) (56)
Lysine Acetylation in Sexual Stage Malaria Parasites Is a Target for Antimalarial Small Molecules (2014) (56)
Diverse MR1-restricted T cells in mice and humans (2019) (55)
Pathway‐selective antagonism of proteinase activated receptor 2 (2014) (54)
Beta-strand mimicking macrocyclic amino acids: templates for protease inhibitors with antiviral activity. (2002) (54)
Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions* (2005) (54)
IL-23 costimulates antigen-specific MAIT cell activation and enables vaccination against bacterial infection (2019) (54)
cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in rats. (1980) (53)
The First Solution Stucture of a Single α-Helical Turn. A Pentapeptide α-Helix Stabilized by a Metal Clip (2000) (53)
Profiling Gene Expression Induced by Protease-Activated Receptor 2 (PAR2) Activation in Human Kidney Cells (2010) (52)
Models for Arginine-Metal Binding. Synthesis of Guanidine and Urea Ligands through Amination and Hydration of a Cyanamide Ligand Bound to Platinum(II), Osmium(III), and Cobalt(III). (1997) (52)
A divergent transcriptional landscape underpins the development and functional branching of MAIT cells (2019) (52)
Comparing sixteen scoring functions for predicting biological activities of ligands for protein targets. (2015) (52)
Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site* (2005) (52)
Substrate-based cyclic peptidomimetics of Phe-Ile-Val that inhibit HIV-1 protease using a novel enzyme-binding mode. (1996) (52)
Design, synthesis, potency, and cytoselectivity of anticancer agents derived by parallel synthesis from alpha-aminosuberic acid. (2006) (52)
Stereoelectronic effects dictate molecular conformation and biological function of heterocyclic amides. (2014) (51)
Ex Vivo Activity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates of Plasmodium falciparum and P. vivax (2010) (50)
An Inhibitor of Phospholipase A2 Group IIA Modulates Adipocyte Signaling and Protects Against Diet-Induced Metabolic Syndrome in Rats (2012) (50)
Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX‐1 and COX‐2 selective inhibitors, and an LTC4 receptor antagonist (2003) (49)
Binding of Copper(II) to the Cyclic Octapeptide Patellamide D (1994) (48)
Consecutive cyclic pentapeptide modules form short alpha-helices that are very stable to water and denaturants. (2004) (48)
Conformationally homogeneous cyclic tetrapeptides: useful new three-dimensional scaffolds. (2003) (47)
Conformational control by thiazole and oxazoline rings in cyclic octapeptides of marine origin. Novel macrocyclic chair and boat conformations (1996) (47)
Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed. (2014) (46)
C5a, but not C5a‐des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2 (2013) (46)
Total synthesis, structure, and oral absorption of a thiazole cyclic peptide, sanguinamide A. (2012) (45)
Amide-Iminol Tautomerism: Effect of Metalation (1994) (45)
Development of C5a receptor antagonists. (1999) (45)
Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides (2015) (45)
Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis (2016) (45)
Conformationally constrained macrocycles that mimic tripeptide beta-strands in water and aprotic solvents. (2002) (44)
Novel cylindrical, conical, and macrocyclic peptides from the cyclooligomerization of functionalized thiazole amino acids. (2001) (44)
Mucosal-Associated Invariant T Cells Augment Immunopathology and Gastritis in Chronic Helicobacter pylori Infection (2018) (44)
Lysine Deacetylases and Regulated Glycolysis in Macrophages. (2018) (43)
Truncated and Helix-Constrained Peptides with High Affinity and Specificity for the cFos Coiled-Coil of AP-1 (2013) (43)
Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis. (2016) (42)
The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1 (2017) (42)
Towards isozyme-selective HDAC inhibitors for interrogating disease. (2012) (42)
Metal clips that induce unstructured pentapeptides to be alpha-helical in water. (2009) (41)
Molecular recognition of macrocyclic peptidomimetic inhibitors by HIV-1 protease. (1999) (40)
Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries. (2004) (40)
Synthesis and structural properties of patellamide A derivatives and their copper(II) compounds. (2002) (39)
Selective hexapeptide agonists and antagonists for human complement C3a receptor. (2010) (39)
Histone deacetylases (HDAC) in physiological and pathological bone remodelling. (2017) (39)
Histone Deacetylase Inhibitors Promote Mitochondrial Reactive Oxygen Species Production and Bacterial Clearance by Human Macrophages (2015) (39)
An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation. (2013) (39)
Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats. (2006) (39)
Amide complexes of (diethylenetriamine)platinum(II) (1992) (39)
The Solution Structure of a Copper(II) Compound of a New Cyclic Octapeptide by EPR Spectroscopy and Force Field Calculations. (1998) (38)
Inhibition of Inflammation and Fibrosis by a Complement C5a Receptor Antagonist in DOCA-Salt Hypertensive Rats (2011) (38)
Regioselective Structural and Functional Mimicry of Peptides - Design of Hydrolytically-Stable Cyclic Peptidomimetic Inhibitors of Hiv-1 Protease (1995) (38)
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells (2018) (38)
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists. (2015) (38)
Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells. (1997) (38)
Inhibition of immune‐complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist (2001) (38)
Crystal Structures of Protein-Bound Cyclic Peptides. (2019) (37)
A convergent solution-phase synthesis of the macrocycle Ac-Phe-[Orn-Pro-D-Cha-Trp-Arg], a potent new antiinflammatory drug. (2003) (37)
A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis. (2005) (37)
Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists (2016) (36)
Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components. (2010) (36)
Template assembled synthetic proteins (TASPS). Are template size, shape, and directionality important in formation of four-helix bundles? (1998) (36)
Inhibitors of β-Amyloid Formation Based on the β-Secretase Cleavage Site (2000) (35)
Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence. (2015) (34)
Conformations of cyclic octapeptides and the influence of heterocyclic ring constraints upon calcium binding (2000) (34)
Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins. (2018) (34)
Biased Signaling by Agonists of Protease Activated Receptor 2. (2017) (34)
PAR2-induced inflammatory responses in human kidney tubular epithelial cells. (2013) (33)
Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. (2007) (33)
Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2. (2020) (33)
Cyclooligomerization of Thiazole-Containing Tetrapeptides. Symmetrical Macrocycles with up to 76 Amino Acids (1999) (33)
Novel helix-constrained nociceptin derivatives are potent agonists and antagonists of ERK phosphorylation and thermal analgesia in mice. (2010) (32)
Helix Nucleation by the Smallest Known α-Helix in Water. (2016) (32)
The possible origin of free radicals from amyloid beta peptides in Alzheimer's disease. (1999) (32)
Constraining Cyclic Peptides to Mimic Protein Structure Motifs (2015) (31)
Inhibitors selective for HDAC6 in enzymes and cells. (2010) (31)
Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. (2018) (31)
Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinase. (1995) (31)
The molecular basis underpinning the potency and specificity of MAIT cell antigens (2020) (31)
Metal clips induce folding of a short unstructured peptide into an alpha-helix via turn conformations in water. Kinetic versus thermodynamic products. (2004) (31)
Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1 (2020) (30)
Solution structures in aqueous SDS micelles of two amyloid beta peptides of A beta(1-28) mutated at the alpha-secretase cleavage site (K16E, K16F). (2000) (30)
Downsizing a human inflammatory protein to a small molecule with equal potency and functionality (2013) (30)
Structural mimicry of two cytochrome b(562) interhelical loops using macrocycles constrained by oxazoles and thiazoles. (2005) (30)
Synthesis, characterization, and reactivity of the (.eta.2-acetone)pentaammineosmium(II) complex (1986) (30)
Proteases Universally Recognize β Strands in Their Active Sites (2005) (30)
Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli (2020) (30)
MAIT Cells Upregulate α4β7 in Response to Acute Simian Immunodeficiency Virus/Simian HIV Infection but Are Resistant to Peripheral Depletion in Pigtail Macaques (2019) (29)
The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis. (2009) (29)
Anti-inflammatory activity of the isoquinoline alkaloid, tetrandrine, against established adjuvant arthritis in rats (1994) (29)
A Novel Bicyclic Enzyme Inhibitor as a Consensus Peptidomimetic for the Receptor-Bound Conformations of 12 Peptidic Inhibitors of HIV-1 Protease (1996) (29)
Mimetics of the peptide beta-strand. (2002) (29)
Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats (2006) (28)
Rv2969c, essential for optimal growth in Mycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidases (2013) (27)
A Novel Potassium-Binding Hydrolysis Product of Ascidiacyclamide: A Cyclic Octapeptide Isolated from the Ascidian Lissoclinum patella. (1996) (27)
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a (2017) (27)
Formation of mononuclear and chloro-bridged binuclear copper(II) complexes of patellamide D, a naturally occurring cyclic peptide: influence of anion and solvent. (2004) (27)
Lipopolysaccharide promotes Drp1‐dependent mitochondrial fission and associated inflammatory responses in macrophages (2020) (27)
Amyloid formation from an α-helix peptide bundle is seeded by 3(10)-helix aggregates. (2011) (27)
A peculiar toxicity manifested by platinum(II)amines in rats: gastric distension after intraperitoneal administration. (1981) (27)
NMR solution structure of the RNA-binding peptide from human immunodeficiency virus (type 1) Rev. (1995) (27)
THE SOLUTION STRUCTURE OF AMYLOID BETA-PEPTIDE (1-40) IN A WATER-MICELLE ENVIRONMENT. IS THE MEMBRANE-SPANNING DOMAIN WHERE WE THINK IT IS? NMR, 10 STRUCTURES (1998) (27)
A Cyclic Metallopeptide Induces α Helicity in Short Peptide Fragments of Thermolysin (2003) (26)
Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonates. (1992) (26)
Left- and right-handed alpha-helical turns in homo- and hetero-chiral helical scaffolds. (2009) (26)
Amination of coordinated nitriles: synthesis of metal complexes of amidines and guanidines (1990) (26)
Interaction of zinc(II) with the cyclic octapeptides, cyclo[Ile(Oxn)-D-Val(Thz)](2) and ascidiacyclamide, a cyclic peptide from Lissoclinum patella (1999) (26)
Cyclic octapeptides containing thiazole. Effect of stereochemistry and degree of flexibility on calcium binding properties (2002) (25)
Therapeutic targets in inflammatory disease. (2005) (25)
Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases (2012) (24)
Designing supramolecular structures from models of cyclic peptide scaffolds with heterocyclic constraints. (2003) (24)
Downsizing Proto-oncogene cFos to Short Helix-Constrained Peptides That Bind Jun. (2017) (24)
Artificially induced MAIT cells inhibit M. bovis BCG but not M. tuberculosis during in vivo pulmonary infection (2020) (24)
Mechanotransduction activates RhoA in the neighbors of apoptotic epithelial cells to engage apical extrusion (2021) (24)
Synthesis, solution structure, and reactivity of oxygen-bound amides on cobalt(III) (1993) (24)
Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens (2020) (24)
MAIT cells regulate NK cell-mediated tumor immunity (2020) (24)
Electrophilic Helical Peptides That Bond Covalently, Irreversibly, and Selectively in a Protein-Protein Interaction Site. (2017) (23)
Comparative Sequence, Structure and Redox Analyses of Klebsiella pneumoniae DsbA Show That Anti-Virulence Target DsbA Enzymes Fall into Distinct Classes (2013) (23)
Organic azide inhibitors of cysteine proteases. (2006) (23)
Over One Hundred Peptide‐Activated G Protein‐Coupled Receptors Recognize Ligands with Turn Structure (2005) (23)
Oxygen versus nitrogen coordination of a urea to (diethylenetriamine)platinum(II) (1993) (23)
Virus-Mediated Suppression of the Antigen Presentation Molecule MR1 (2020) (22)
Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3. (2007) (22)
Nutrient and immune sensing are obligate pathways in metabolism, immunity, and disease (2015) (22)
Protease-Activated Receptor-2 Peptides Activate Neurokinin-1 Receptors in the Mouse Isolated Trachea (2006) (22)
An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice (2017) (22)
Base-catalyzed hydration of cobalt(III)-coordinated dimethylcyanamide and linkage isomerization of the derived N-bound dimethylurea complex (1983) (22)
Potent heterocyclic ligands for human complement c3a receptor. (2014) (22)
New Treatment Strategies for Dengue and other Flaviviral Diseases (2006) (22)
Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis (2018) (22)
Small molecule inhibitors of disulfide bond formation by the bacterial DsbA-DsbB dual enzyme system. (2015) (22)
Development of cell‐penetrating peptide‐based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions (2016) (21)
Catalytically active Dengue virus NS3 protease forms aggregates that are separable by size exclusion chromatography. (2002) (21)
Macrocyclic peptidomimetics: potential for drug development. (1998) (21)
Profiling the Enzymatic Properties and Inhibition of Human Complement Factor B* (2007) (21)
Irritancy and anti-inflammatory activity of bis(eta 5-cyclopentadienyl)titanium(IV) complexes in rats. (1987) (21)
Factors Influencing the Nitrogen Vs Oxygen Bonding Mode of Amides Bound to Pentaamminecobalt(Iii) and the Kinetics and Mechanism of Rearrangement (1991) (21)
Protease activated receptor 2 (PAR2) modulators: a patent review (2010–2015) (2016) (20)
Inhibition of immune‐complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist (2002) (20)
Regioselective synthesis of antiparallel loops on a macrocyclic scaffold constrained by oxazoles and thiazoles. (2002) (20)
Inhibition of HIV-1 proteinase by non-peptide carboxylates. (1991) (19)
Antiproliferative and phenotype-transforming antitumor agents derived from cysteine. (2004) (19)
C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue (2014) (19)
Contiguous hydrophobic and charged surface patches in short helix-constrained peptides drive cell permeability. (2018) (19)
Protein α-turns recreated in structurally stable small molecules. (2011) (19)
A refined agonist pharmacophore for protease activated receptor 2. (2007) (18)
Oxygen versus Nitrogen Bonding of Carboxamides to Pentaammineruthenium(II/III). (1997) (18)
An interaction between the methyltransferase and RNA dependent RNA polymerase domains of the West Nile virus NS5 protein. (2013) (18)
Crystal structures of highly constrained substrate and hydrolysis products bound to HIV-1 protease. Implications for the catalytic mechanism. (2008) (18)
Noncovalent tripeptidyl benzyl- and cyclohexyl-amine inhibitors of the cysteine protease caspase-1. (2010) (18)
Potent Small Agonists of Protease Activated Receptor 2. (2016) (18)
Activation of Thiourea Bound through Sulfur to Pentaammineruthenium(III): Structure and Reactivity. (1997) (17)
Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain. (2016) (17)
Helixconstraints and amino acid substitution in GLP-1 increase cAMP and insulin secretion but not beta-arrestin 2 signaling. (2017) (17)
Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells. (2018) (16)
Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease‐activated receptor‐2 (2016) (16)
Zinc monoglycerolate — A slow-release source of therapeutic zinc: Solubilization by endogenous ligands (1992) (16)
Quinazolinone derivatives as inhibitors of homologous recombinase RAD51. (2017) (16)
Chemically Diverse Helix-Constrained Peptides Using Selenocysteine Crosslinking. (2018) (16)
Organization of amino acids using a metallotriazacyclononane template (1997) (16)
Cyclic alpha-conotoxin peptidomimetic chimeras as potent GLP-1R agonists. (2015) (16)
Platinum drugs: Combined anti-lymphoproliferative and nephrotoxicity assay in rats (1980) (16)
Tolyporphin Macrocycles from the Cyanobacterium Tolypothrix nodosa Selectively Bind Copper and Silver and Reverse Multidrug Resistance. (2017) (16)
Synthesis of the thiazole-thiazoline fragment of largazole analogues. (2011) (16)
Connecting hydrophobic surfaces in cyclic peptides increases membrane permeability. (2020) (16)
Inhibitors of beta-amyloid formation based on the beta-secretase cleavage site. (2000) (15)
Crystal Structure of the Dithiol Oxidase DsbA Enzyme from Proteus Mirabilis Bound Non-covalently to an Active Site Peptide Ligand (2014) (15)
Biphasic Response of the Metallothionein Promoter to Ultraviolet Radiation in Human Melanoma Cells (1997) (15)
Linkage isomerization of (urea)pentaammineruthenium(III) and inter- vs. intramolecular substitution on ruthenium(III) (1985) (15)
Targeting quorum sensing and competence stimulation for antimicrobial chemotherapy. (2012) (15)
A dual-purpose synthetic colloidal platform for protease mapping: substrate profiling for Dengue and West Nile virus proteases. (2008) (15)
Diet-induced obesity , adipose inflammation , and metabolic dysfunction correlating with PAR 2 expression are attenuated by PAR 2 antagonism (2013) (15)
Nonpeptide ligands that target peptide-activated GPCRs in inflammation. (2005) (15)
C5a Receptor (CD88) Inhibition Improves Hypothermia-Induced Neuroprotection in an In Vitro Ischemic Model (2012) (15)
Inhibitors of class I histone deacetylases attenuate thioacetamide‐induced liver fibrosis in mice by suppressing hepatic type 2 inflammation (2019) (15)
A cyclic beta-strand tripeptide with an alpha-helix like CD spectrum. (2009) (15)
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery (2015) (15)
CXCL16 Stimulates Antigen-Induced MAIT Cell Accumulation but Trafficking During Lung Infection Is CXCR6-Independent (2020) (14)
Inhibition of HIV-1 proteinase by metal ions. (1992) (14)
Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor. (2001) (14)
Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors (2007) (14)
Ammonia and carbon dioxide from urea. A multinuclear NMR study of the activation of urea by platinum(II) (1995) (13)
Regulators of the anaphylatoxin C5a (2000) (13)
Protease activated receptor 2 controls myelin development, resiliency and repair (2017) (13)
Structure-activity relationships for substrate-based inhibitors of human complement factor B. (2009) (13)
Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. (2020) (13)
A novel long-range n to π* interaction secures the smallest known α-helix in water. (2019) (13)
Efficient chemical synthesis of human complement protein C3a. (2013) (13)
Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro (2020) (12)
Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infection (2021) (12)
An efficient Fmoc strategy for the rapid synthesis of peptide para-nitroanilides (2000) (12)
A Convergent Solution‐Phase Synthesis of the Macrocycle Ac‐Phe‐[Orn‐Pro‐D‐Cha‐Trp‐Arg], a Potent New Antiinflammatory Drug. (2003) (12)
Downsizing the BAD BH3 peptide to small constrained α-helices with improved ligand efficiency. (2016) (12)
Anti–Inflammatory activity of a holothurian (sea cucumber) food supplement in rats (1994) (12)
A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling (2012) (12)
Cobalt-induced facile degradation of phenylurea to ammonia, carbon dioxide, and anilinium ion and other reactions of linkage isomeric cobalt(III) complexes of phenylurea (1989) (12)
Unexpected photolytic decomposition of alkyl azides under mild conditions. (2007) (12)
The α-Proteobacteria Wolbachia pipientis Protein Disulfide Machinery Has a Regulatory Mechanism Absent in γ-Proteobacteria (2013) (12)
Linkage isomerization of (formamide-N)- and (acetamide-N)pentaamminecobalt(III) ions in water, dimethyl sulfoxide, and sulfolane (1990) (12)
Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease (1996) (11)
HDACs and their inhibitors in immunology: teaching anticancer drugs new tricks (2012) (11)
A Selective and Versatile Synthesis of Substituted Chromones via Addition of Phenols to Dimethyl Acetylenedicarboxylate (1995) (11)
Mapping transmembrane residues of proteinase activated receptor 2 (PAR2) that influence ligand‐modulated calcium signaling (2017) (11)
Computer modelling and synthesis of deoxy and monohydroxy analogues of a ribitylaminouracil bacterial metabolite that potently activates human T cells. (2019) (11)
SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR, 10 STRUCTURES (1998) (11)
Reversible linkage isomerization of pentaamminecobalt(III) complexes of urea and its N-methyl derivatives (1988) (11)
PAR2 Modulators Derived from GB88. (2016) (11)
PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR (2020) (11)
Virtual Screening of Peptide and Peptidomimetic Fragments Targeted to Inhibit Bacterial Dithiol Oxidase DsbA (2015) (11)
Insecticidal activities of histone deacetylase inhibitors against a dipteran parasite of sheep, Lucilia cuprina (2017) (10)
A general synthetic route to pentaamminecobalt(III) complexes of N-bonded amides, ureas, carbamates, sulfinamides, sulfonamides and sulfamate (1990) (10)
Histone deacetylase enzymes as drug targets for the control of the sheep blowfly, Lucilia cuprina (2015) (10)
Linkage isomerism in the binding of pentapeptide Ac-His(Ala)3His-NH2 to (ethylenediamine)palladium(II): effect of the binding mode on peptide conformation. (2008) (10)
Fortified Coiled Coils: Enhancing Mechanical Stability with Lactam or Metal Staples (2020) (10)
Characterization of Human Mucosal‐associated Invariant T (MAIT) Cells (2019) (10)
Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation. (2009) (10)
'Clean' or 'Dirty' : Just How Selective do Drugs Need to Be? (2008) (9)
Binding of the immunosuppressant peptide cyclosporine a to calcium, zinc and copper. Is cyclosporine a an ionophore? (1995) (9)
Lymphoid suppression by cis-platinum(II) amines. What are the active agents? (1982) (9)
PAR 2-induced inflammatory responses in human kidney tubular epithelial cells (2013) (9)
Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro* (2016) (9)
Human MAIT cells respond to and suppress HIV-1 (2021) (9)
Product release is rate-limiting for catalytic processing by the Dengue virus protease (2016) (9)
Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis (2019) (8)
Thiazoles in Peptides and Peptidomimetics (2015) (8)
Transdermal delivery of inorganic complexes as metal drugs or nutritional supplements. (1991) (8)
Atypical TRAV1-2− T cell receptor recognition of the antigen-presenting molecule MR1 (2020) (8)
Folding pentapeptides into left and right handed alpha helices (2012) (8)
Cycloadditions of isobenzofuran to a constrained template bearing neighboring dienophiles. (2003) (8)
Total Synthesis of Mycobacterium tuberculosis Dideoxymycobactin-838 and Stereoisomers: Diverse CD1a-Restricted T Cells Display a Common Hierarchy of Lipopeptide Recognition. (2017) (8)
Studies of the interaction of potassium(I), calcium(II), magnesium(II), and copper(II) with cyclosporin A. (2003) (8)
Cell phenotype as a target of drug therapy in chronic inflammatory diseases. (2000) (8)
Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2 (2015) (8)
Nitrogen- and oxygen-bonded urethane: hydrolysis and linkage isomerization of [(NH3)5Co(NH2CO2C2H5)]3+ and [(NH3)5CoOC(NH2)OCH2CH3]3+ (1990) (8)
Characterization and Purification of Mouse Mucosal‐Associated Invariant T (MAIT) Cells (2019) (8)
MR1-Restricted T Cells with MAIT-like Characteristics Are Functionally Conserved in the Pteropid Bat Pteropus alecto (2020) (8)
Matching Cavities in G Protein-Coupled Receptors to Infer Ligand-Binding Sites (2012) (8)
Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell Proliferation. (2020) (8)
Hepta and octapeptide agonists of protease‐activated receptor 2 (2007) (8)
Identification and characterization of bi-thiazole-2,2'-diamines as kinase inhibitory scaffolds. (2013) (8)
Toward peptide-based inhibitors as therapies for Parkinson's disease. (2015) (7)
cis-Platinum(II) amines: toxicities and immunosuppressant/anti-arthritic activities. (1981) (7)
Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception. (2015) (7)
An efficient Fmoc strategy for the rapid synthesis of peptide para-nitroanilides (2006) (7)
Targeting Histone Deacetylase 1 (Hdac 1) to Suppress Both Inflammation and Bone Loss in Arthritis (2013) (7)
Identification and Phenotype of MAIT Cells in Cattle and Their Response to Bacterial Infections (2020) (7)
Facile and stereoselective condensation of acetone with ammonia ligands on cobalt(III): structure of a N-bonded cyanate complex containing the 2-methyl-2-amino-4-imino-pentane ligand (1999) (7)
Oxygen- and sulfur-bonded thiosulfatopentaamminecobalt(III) (1983) (7)
Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a Receptor. (2017) (7)
Chemical Approaches to Modulating Complement-Mediated Diseases. (2017) (6)
Chemical Modulators of Mucosal Associated Invariant T Cells. (2021) (6)
A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy (2020) (6)
Pharmacological inhibition of protease‐activated receptor‐2 reduces crescent formation in rat nephrotoxic serum nephritis (2019) (6)
Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition (2020) (6)
INHIBITORS OF CYCLO-OXYGENASE-2 AND SECRETORY PHOSPHOLIPASE A 2 (GROUP IIa) PRESERVE BONE ARCHITECTURE FOLLOWING OVARIECTOMY IN ADULT RATS (2006) (6)
Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha (1993) (6)
Mimicking extended conformations of protease substrates (1997) (6)
A new dinuclear amine-cobalt(III) complex containing two bridging amide ions (1993) (6)
Glucuronic acid as a helix-inducing linker in short peptides. (2018) (6)
Facile synthesis of mono- and bis-methylated Fmoc-Dap, -Dab and -Orn amino acids. (2015) (5)
HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates. (2021) (5)
Potent complement C3a receptor agonists derived from oxazole amino acids: Structure-activity relationships. (2015) (5)
CD8 coreceptor engagement of MR1 enhances antigen responsiveness by human MAIT and other MR1-reactive T cells (2022) (5)
Simple cis-epoxide-based inhibitors of HIV-1 protease (1997) (5)
Oxazole-Benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1A and Reduce Viral Replication (2019) (5)
PAR2 Activation on Human Kidney Tubular Epithelial Cells Induces Tissue Factor Synthesis, That Enhances Blood Clotting (2021) (5)
Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake (2022) (5)
Structure of a novel protonated oxadiazine: an unusual heterocycle from the cycloaddition of a ketone with nitriles (1996) (5)
QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites. (2022) (4)
Beta‐Strand Mimetics (2005) (4)
Tuning Electrostatic and Hydrophobic Surfaces of Aromatic Rings to Enhance Membrane Association and Cell Uptake of Peptides (2022) (4)
Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity. (2016) (4)
Inhibition of the master regulator of Listeria monocytogenes virulence enables bacterial clearance from spacious replication vacuoles in infected macrophages (2022) (4)
WEST NILE VIRUS NS 3 PROTEASE : INSIGHTS INTO SUBSTRATE BINDING AND PROCESSING THROUGH COMBINED MODELLING , PROTEASE MUTAGENESIS AND KINETIC STUDIES (2006) (4)
Mimicking extended conformations of protease substrates: Designing cyclic peptidomimetics to inhibit HIV-1 protease (1997) (4)
Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilities. (2019) (4)
Discovery of Potent Cyclic Antagonists of Human C5a Receptors (2005) (4)
Linkage Isomeric Pentaamminecobalt(Iii) Complexes of Methanesulfinamide (1990) (4)
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease. (2022) (4)
A Novel Long‐Range n to π* Interaction Secures the Smallest known α‐Helix in Water (2019) (4)
Alpha helix nucleation by a simple cyclic tetrapeptide (2016) (4)
Protease Inhibitors: Current Status and Future Prospects (2000) (4)
Mucosal-Associated Invariant T Cell Effector Function Is an Intrinsic Cell Property That Can Be Augmented by the Metabolic Cofactor α-Ketoglutarate (2021) (4)
Helical cyclic pentapeptides constrain HIV-1 Rev peptide for enhanced RNA binding (2014) (4)
Conformational Control by Thiazole and Oxazoline Rings in Cyclic Octapeptides of Marine Origin. Novel Macrocyclic Chair and Boat Conformations. (1997) (4)
Current approaches to peptidomimetics (2003) (4)
Characterisation of TNF-α-related peptides by high-performance liquid chromatography-mass spectrometry and high-performance liquid chromatography-tandem mass spectrometry (1993) (3)
Mimetics of the Peptide β‐Strand (2003) (3)
Connecting Hydrophobic Surfaces in Cyclic Peptides Increases Membrane Permeability (2020) (3)
Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines (2021) (3)
Editorial [Hot Topic: Latest Developments in the Treatment of Inflammatory Disease (Guest Editor: David Fairlie)] (2005) (3)
Homogeneous Catalysis: Catalytic Intramolecular Conversion of 1,4‐Dialdehydes to γ‐Lactones. (1990) (3)
Towards Protein Surface Mimetics (1998) (3)
PAR2-Induced Tissue Factor Synthesis by Primary Cultures of Human Kidney Tubular Epithelial Cells Is Modified by Glucose Availability (2021) (3)
Phospholipase A2 inhibitor attenuates NOx production and myocardial damage in the cardiac allograft (2002) (3)
Cyclooligomerization of a helix-bearing template into macrocycles bearing multiple helices. (2008) (2)
Protease‐activated receptor 2 does not contribute to renal inflammation or fibrosis in the obstructed kidney (2019) (2)
The histone deacetylase Hdac7 supports LPS‐inducible glycolysis and Il‐1β production in murine macrophages via distinct mechanisms (2021) (2)
Synthesis, solution structure, and reactivity of oxygen-bound amides on cobalt(III). [Erratum to document cited in CA118(14):138542q] (1993) (2)
Targeting Class IIa HDACs: Insights from Phenotypes and Inhibitors. (2021) (2)
The balance of interleukin‐12 and interleukin‐23 determines the bias of MAIT1 versus MAIT17 responses during bacterial infection (2022) (2)
Small Molecules that Mimic Components of Bioactive Protein Surfaces (2004) (2)
Cobalt-induced facile degradation of phenylurea to ammonia, carbon dioxide, and anilinium ion and other reactions of linkage isomeric cobalt(III) complexes of phenylurea [Erratum to document cited in CA110(22):199921u] (1990) (2)
Activation of protease‐activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome (2020) (2)
Structures of peptide agonists for human protease activated receptor 2. (2012) (2)
Legionella protection and vaccination mediated by Mucosal Associated Invariant T (MAIT) cells (2017) (2)
A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells (2022) (2)
De novo macrocyclic peptides for inhibiting, stabilizing, and probing the function of the retromer endosomal trafficking complex (2020) (2)
Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg (2012) (2)
PANCREATIC SECRETORY PHOSPHOLIPASE A2 (IIa) WITH ANTI-INFLAMMATORY ACTIVITY (2003) (2)
Non-peptide inhibitors of HIV-1 protease. Synthesis and structural evaluation of symmetric and non-symmetric naphthalenesulfonic acid analogues (1996) (2)
Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity. (2021) (1)
Differential location of NKT and MAIT cells within lymphoid tissue (2021) (1)
A cyclic metallopeptide induces alpha helicity in short peptide fragments of thermolysin. (2003) (1)
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma (2018) (1)
Complement Promotes Gvhd through Suppressing Autophagy in Recipient Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation in Mice (2017) (1)
Novel agonists and antagonists for protease activated receptor 2 (2011) (1)
Targeting Host Complement C3a/C5a Receptors to Control of Acute Graft-Versus-Host Disease in Mice (2015) (1)
Late‐Stage Hydrocarbon Conjugation and Cyclisation in Synthetic Peptides and Proteins (2021) (1)
Treatment of osteoarthritis (2005) (1)
Diverse MR1-restricted T cells in mice and humans (2019) (1)
Editorial (Hot Topic: Chemical Biology Down Under) (2012) (1)
Small peptides Do not inhibit human non-pancreatic secretory phospholipase-A(2) (Type IIA). (2000) (1)
High Cell Permeability Does Not Predict Oral Bioavailability for Analogues of Cyclic Heptapeptide Sanguinamide A (2020) (1)
MAIT cells protect against pulmonary Legionella longbeachae infection (2018) (1)
Altering T-Cell Responses in the Metastatic Niche Complement C 5 a Receptor Facilitates Cancer Metastasis (2014) (1)
Synthesis, characterization, and reactivity of the (η2-acetone)pentaammineosmium(II) complex (1987) (1)
Parallel synthesis af anticancer, antiinflammatory and antiviral agents derived from L- and D- amino acids (2008) (1)
A Selective and Versatile Synthesis of Substituted Chromones via Addition of Phenols to Dimethyl Acetylenedicarboxylate. (1995) (1)
Shedding light on MHC class I antigen loading: a UV-labile peptide ligand approach (2012) (1)
Recent Advances in β‐Strand Mimetics (2011) (1)
Designing metalloinhibitors for delivery to peptide receptors in enzymes. (1993) (1)
Corrections to Selective Hexapeptide Agonists and Antagonists for Human Complement C3a Receptor (2010) (1)
Base-Sensitivity of Arginine Alpha-Ketoamide Inhibitors of Serine Proteases (2009) (1)
Plasmodium falciparum histone deacetylases: enzymes involved in gene regulation as new antimalarial drug targets (2007) (1)
Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice (2021) (1)
Hydrolases (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Short peptide alpha helices induced by multiple metal clips (2003) (1)
Regioselective Structural and Functional Mimicry of Peptides. Design of Hydrolytically-Stable Cyclic Peptidomimetic Inhibitors of HIV-1 Protease. (1996) (1)
This information is current as in Macrophages by Complement Protein C5a Primary Human Monocytes but Suppressed Lipopolysaccharide Are Amplified in Inflammatory Responses Induced by (2014) (0)
Inhibiting Histone Deacetylases Expressed in Human Periodontal Tissues Prevents Bone Loss in An Animal Model of Periodontal Disease (2011) (0)
Heterocycles for switching GPCR ligand conformation and activity (2019) (0)
New amino acid derivatives useful for the treatment of inflammatory disease or condition e.g. rheumatic arthritis (2007) (0)
Conformationally constrained small molecule antagonists of C5a. (1997) (0)
Design and synthesis of new cavitands which are stereochemically rigid, hydrophobic and internally functionalised (1992) (0)
Multifrequency EPR spectra of Cu(II) and Ag(II) tolyporphins (1995) (0)
Homogeneous Catalysis. Conversion of 4-Pentenals to Cyclopentanones by Efficient Rhodium-Catalyzed Hydroacylation. (1988) (0)
Development of a catalytically active recombinant West Nile NS3 protease and the identification of key enzyme-substrate interactions by site-directed mutagenesis (2005) (0)
A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells (2010) (0)
Hydrolases (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
Construction and characterization of the dengue 2 virus NS3 protease and its mutants (2001) (0)
Spontaneously Hypertensive Rats in Young 2 IIA Secretory Phospholipase A Antifibrotic Activity of an Inhibitor of Group (2006) (0)
Multiple targets for antiviral inhibitors (2006) (0)
Concise synthesis of the thiazole-thiazoline fragment of largazole (2012) (0)
MAIT cells: Friend or Foe in recognising microbial vitamin metabolites presented by the MHC-I-related molecule MR1 (2016) (0)
Priming programed Mucosal-Associated Invariant T cells protect against systemic or local bacterial infection (2020) (0)
Effect of a protease-activated receptor-2 antagonist (GB88) on inflammation-related loss of alveolar bone in periodontal disease. (2023) (0)
Design and synthesis of inhibitors of HIV-1 protease (1994) (0)
A novel strategy for the design of potent peptidomimetic inhibitors of proteolytic enzymes: Application to HIV-1 protease. (1997) (0)
Drugs and drug-like molecules can modulate mucosal-associated invariant T cell function (2017) (0)
The complement C5a receptor facilitates cancer metastasis by altering T cell responses in metastases-targeted organs (TUM2P.883) (2014) (0)
Prevention of ischemia/reperfusion injuries in rats by a new small molecule C5a receptor antagonist (2001) (0)
Towards Modular Alpha-Helices: Comformationally Stable Cyclic Pentapeptides as Alpha-Turn Mimetics (2004) (0)
Catalyst‐Free N‐Arylation Using Unactivated Fluorobenzenes. (2013) (0)
Inhibition of both class I and class II histone deacetylases is required to effectively inhibit osteoclast bone resorption in vivo and in vitro (2009) (0)
Front Cover: Late‐Stage Hydrocarbon Conjugation and Cyclisation in Synthetic Peptides and Proteins (ChemBioChem 10/2021) (2021) (0)
Structure of human MAIT TCR in complex with human MR1-6-FP (2013) (0)
Metal clips for folding peptides (2001) (0)
The molecular basis underpinning the potency and specificity of MAIT cell antigens (2020) (0)
Mining physicochemical features that contribute to oral bioavailability in peptide middle space (2014) (0)
Abstract 15: The Novel Complement C3ar Antagonist Jr14a Is Neuroprotective In Stroke (2022) (0)
Symmetrical and Nonsymmetrical Nonpeptide Inhibitors of Hiv-1 Protease - Naphthalenesulfonic Acid-Derivatives (1993) (0)
Metallopeptides in Alzheimer's Disease (2000) (0)
Helix inducing metal clips in short peptides (2003) (0)
Novel inhibitors of DENV NS2B/NS3pro protease (2013) (0)
How MAIT cells control the growth of intracellular mycobacteria (P4381) (2013) (0)
Inhibition of Human Secretory Phospholipase A2 (Type IIA) (2000) (0)
A broad family of MR1-restricted T cells (2016) (0)
Over 100 peptide-activated GPCRS recognize turn motifs in ligands (2005) (0)
Structure of a Novel Protonated Oxadiazine: An Unusual Heterocycle from the Cycloaddition of a Ketone with Nitriles. (1996) (0)
Drugs/drug analogues modulate MAIT cell function in an MR1-dependent manner (2016) (0)
Development of a catalytically active recombinant West Nile virus NS3 protease and the identification of key enzyme-substrate and enzyme-cofactor interactions by site-directed mutagenesis (2005) (0)
Characterization of the alpha-proteobacteria Wolbachia pipientis protein disulphide machinery reveals a regulatory mechanism absent in gamma-proteobacteria (2014) (0)
Towards orally bioavailable peptides and peptidomimetics (2011) (0)
An interaction between the methyltransferase and RNA dependent RNA polymerase 1 domains of the West Nile virus NS 5 protein 2 Running title : An interaction between the WNV NS 5 MTase-POL 3 (2013) (0)
Modelling of the C5a receptor by iterative mutation (2010) (0)
Defining the ligand binding site on the human C5a receptor (2006) (0)
Regulating protein and peptide activated GPCRs (2009) (0)
MEDI 181-Alpha helix induction in HIV REV34-50 by N-terminal nucleators (2006) (0)
Vitamin B2 related molecules that activate T cells (2017) (0)
Reversible Linkage Isomerization of Pentaamminecobalt(III) Complexes of Urea and Its N-Methyl Derivatives. (1988) (0)
HDAC7 is an immunometabolic switch triaging danger signals for engagement of antimicrobial versus inflammatory responses in macrophages. (2023) (0)
Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation (2019) (0)
Fluorobenzene derivatives as multifunctional tools (2012) (0)
Validation of non-invasive transcutaneous method for glomerular filtration rate (GFR) in obese mice (2018) (0)
Modelling studies of molecular receptors (1998) (0)
Correction: Downsizing the BAD BH3 peptide to small constrained α-helices with improved ligand efficiency. (2016) (0)
Stereoelectronic Effects on Dienophile Separation Influence the Diels–Alder Synthesis of Molecular Clefts (2017) (0)
Amination of Coordinated Nitriles: Synthesis of Metal Complexes of Amidines and Guanidines. (1990) (0)
New cyclic peptide or peptidomimetic compounds, are G-protein coupled receptor antagonists useful for treating inflammatory disorders such as rheumatoid arthritis, reperfusion injury or dermal inflammation (2003) (0)
DNA damage- induced apoptosis in the BL30A Burkitt’s lymphoma cell line requires caspase-8 and mitochondrial p53 activity. (2011) (0)
Downsizing Proteins Without Losing Potency or Function (2015) (0)
COMP 264-Unraveling the mechanism of antagonism for human C5a receptor: Comparison of three structurally different antagonists (2008) (0)
Structure of human MAIT TCR in complex with human MR1-RL-6-Me-7-OH (2013) (0)
Conformations of Cyclic Octapeptides and the Influence of Heterocyclic Ring Constraints Upon Calcium Binding. (2000) (0)
Organic Azide Inhibitors of Cysteine Proteases [J. Am. Chem. Soc. 2006, 128, 12396−12397]. (2007) (0)
Tetramer identification of functional mouse mucosal associated invariant T cells (INC6P.352) (2014) (0)
Investigation of the West Nile virus NS3 protease by tandem use of site-directed mutagenesis and substrate modification (2006) (0)
Potent inhibitors of West Nile Virus NS2B/NS3 protease (2009) (0)
Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages (2023) (0)
Multifrequency EPR studies of the mono- and bi-nuclear copper(II) complexes formed with the marine cyclic octapeptides patellamide D and ascidiacyclamide (1996) (0)
“Clean” or “Dirty” — Just How Selective Do Drugs Need to Be? (2009) (0)
Cyclic Octapeptides Containing Thiazole. Effect of Stereochemistry and Degree of Flexibility on Calcium Binding Properties. (2010) (0)
Simple cis‐Epoxide‐Based Inhibitors of HIV‐1 Protease. (1998) (0)
Genome wide expression profiling of hydroxamate-based HDAC inhibitors against P. falciparum (2010) (0)
Characterisation of TNF-alpha-related peptides by high-performance liquid chromatography-mass spectrometry and high-performance liquid chromatography-tandem mass spectrometry. (1993) (0)
Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a (2017) (0)
Developing antiviral targets for RSV via mutational analysis of HRB and HRC domains using a novel fusion assay system (2006) (0)
Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126] (2016) (0)
Supplementary Figure S1 for AJP-Renal submission (2019) (0)
Linkage Isomerization of (Urea)pentaammineruthenium(III) and Inter- vs. Intramolecular Substitution on Ruthenium(III). (1986) (0)
Template-assembled peptide loops, helices, sheets, and nanofibers (2003) (0)
Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling Profiles. (2022) (0)
Tetramer identification of functional mouse mucosal associated invariant T (MAIT) cells (2015) (0)
Palladium induced alpha helicity in short peptides. (2002) (0)
The reaction between metal ions and short peptides (2000) (0)
Tumor‐Associated Antigenic Peptides as Vaccine Candidates (2009) (0)
Toward more orally bioavailable inhibitors of phospholipase A(2) GIIA (pla2g2a) to treat chronic inflammation (2013) (0)
Common drugs modulate mucosal-associated invariant T cell function (2016) (0)
Conformationally constrained cyclic mimetics of protein and peptide surfaces. (1997) (0)
THE LIVER IN THE REGULATION OF IRON HOMEOSTASIS : ROLE OF HEPCIDIN AND TRANSFERRIN RECEPTOR 2 (2005) (0)
Erratum: Latest developments in the treatment of inflammatory disease (Current Medicinal Chemistry (2005) vol. 12 (25) (2923-224)) (2007) (0)
Supplementary Data tables for: Orally absorbed cyclic peptides (2019) (0)
Molecular basis underpinning metabolite-mediated T-cell immunity (2021) (0)
Quantitative affinity measurement of small molecule ligand binding to major histocompatibility complex class-I–related protein 1 MR1 (2022) (0)
Alpha-helix induction in short peptides using metal clips (2005) (0)
MEDI 180-Effects of cyclization constraints on helix/turn peptide structures (2006) (0)
Complement and inflammation: New antagonists of C5a receptors. (2000) (0)
Temporal perturbation of histone deacetylase activity reveals a requirement for HDAC1-3 in mesendoderm cell differentiation. (2022) (0)
MEDI 256-Activation and inhibition of latent serine proteases, complement factors B and C2 (2008) (0)
MR1 dependent MAIT cell activation is regulated by autophagy associated proteins (2022) (0)
Venom Composition and Bioactive Rf-Amide Peptide Toxins of the Saddleback Caterpillar, Acharia Stimulea (Lepidoptera: Limacodidae) (2023) (0)
Helical structure in cyclic peptides: effect of N-methyl amides versus esters. (2022) (0)
Editorial: chemical biology Down Under. (2012) (0)
Coordination with Pd(en)2+ imposes an a-helical structure on a pentapeptide (2000) (0)
Reactivity of commercially available Fmoc amino acids: supplementary information (2015) (0)
IL-23 co-stimulation drives antigen-specific MAIT cell activation and enables vaccination against bacterial infection (2019) (0)
Deactivation of the chlorosulfonate ion coordinated to pentaamminecobalt(III) (2002) (0)
The selective binding of tolyporphins to metal ions (1995) (0)
Antigen-specific MAIT cell subsets involved in TB immunity (INC2P.420) (2015) (0)
Synthesis of cavitands as catalytic environments (1991) (0)
HIV-1 PROTEASE COMPLEXED WITH A MACROCYCLIC PEPTIDOMIMETIC INHIBITOR (2000) (0)
Thymic precursors to the mucosal-associated invariant T cell lineage (2016) (0)
NMR solution structure for di-sulfide 11mer peptide (2015) (0)
NMR solution structure for lactam (5,9) 11mer (2015) (0)
Protease activated-receptor-2 induced inflammation and fibrosis is mediated in part through activation of transforming growth factor-beta signalling (2016) (0)
HIV-1 REV PROTEIN (RESIDUES 34-50) (1995) (0)
Recipient mucosal-associated invariant T cells control graft-versus-host-disease within the colon. (2018) (0)
Peptide bundles: Loops, helices, strands and sheets (2006) (0)
Inhibiting Virulence in E. coli: Screening of Peptidomimetics Ttargeting the DsbA Disulfide Bond Formation Machinery (2013) (0)
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc (2021) (0)
Pharmacological Inhibition of Protease-Activated Receptor 2 (Par2) Reduces Crescent Formation in Rat Anti-Gbm Disease (2016) (0)
NMR structure of a short hydrophobic 11mer peptide in 25 mM SDS solution (2015) (0)
T-cell antigen formed from distinct metabolic pathways (2015) (0)
Inhibiting, stabilising and probing the function of the Retromer endosomal trafficking complex through the novel macrocyclic peptides (2021) (0)
Protease-activated receptor-2 and renal carcinogenesis (2010) (0)
RESEARCH PAPER Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats (2010) (0)
Helical Agonist of Nociceptin (NOP) Receptor (2011) (0)
Cyclic peptides as metal ion receptors (1996) (0)
Control of peptide conformation by Palladium(II) coordination (2001) (0)
Suppression of MR1 by human cytomegalovirus inhibits MAIT cell activation (2023) (0)
Towards Arginine Mimetics (2000) (0)
NMR solution structure of oxidized KpDsbA (2013) (0)
Tautomerism in Amide Complexes (1992) (0)
A unified view of neighbour cell engagement during apoptotic cell extrusion (2020) (0)
The selective binding of metal ions by tolyporphins (1997) (0)
CB&DD Editorial Advisory Board (seventh in series) (2006) (0)
Effects of conformational constraints in cyclic octapeptides of marine origin (1996) (0)
Antiviral activity in cell culture of potent inhibitors targeting the West Nile Virus NS2B/NS3 protease (2009) (0)
In vitro catalytic activity of recombinant forms of the dengue virus NS3 protease (2001) (0)
MoleculesIs a Target for Antimalarial Small Lysine Acetylation in Sexual Stage Malaria (2014) (0)
Sneaking up on West Nile Virus NS2B/NS3 protease subcellular activity utilising dye-quenched substrates (2010) (0)
Are ketoamides suitable electrophilic isosteres for incorporation in inhibitors of serine proteases (2001) (0)
Transcriptional profiling the effects of hydroxamate-based HDAC inhibitors in P. falciparum (2010) (0)
Model of Inflammatory Bowel Disease Protects against Disease Pathology in a Rat A Potent Human C5a Receptor Antagonist (2003) (0)
Expression and characterization of a catalytically active form of the Dengue virus NS3 protease (2000) (0)
Conformationally restricted cyclic peptides incorporating oxazoline and thiazole ring constraints. (1998) (0)
RNA-sequencing analysis of biopsies from chronic liver disease patients identifies gene signatures associated with progressive liver disease (2018) (0)
C5a Receptor (CD88) Inhibition Improves Hypothermia-Induced Neuroprotection in an In Vitro Ischemic Model (2012) (0)
A General Synthetic Route to Pentaamminecobalt(III) Complexes of N- Bonded Amides, Ureas, Carbamates, Sulfinamides, Sulfonamides and Sulfamate. (1991) (0)
Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition (2020) (0)
Activity of the histone deacetylase (HDAC) inhibitor AR-42 in a murine malaria model (2017) (0)
YS-201002500 sm miscellaneous information (2013) (0)
The role of oxazoline and thiazole ring constraints in cyclic peptides of marine origin. (1997) (0)
Homology model of the dengue 2 virus NS3 protease: Interactions with NS2B co-factor (1999) (0)
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles (2019) (0)
Self-condensation of a thiazole-peptide bearing a 21-membered loop into a library of giant macrocycles with multiple orthogonal loops. (2006) (0)
New cysteine derivatives with antiproliferative activity on melanoma cells. (2006) (0)
CHARACTERIZING PEPTIDE ALPHA HELICES VIA COLD ION SPECTROSCOPY OF MODEL COMPOUNDS (2018) (0)
A new C5a receptor antagonist inhibits monoarticular arthritis in the rat (2001) (0)
MR1 is an endoplasmic reticulum-resident sensor of vitamin B metabolites (2016) (0)
Mucosal-associated invariant T cells are an important source of TNF in rheumatoid arthritis (2017) (0)
Synthesis, SAR, and Pharmacological Activities of a Series of Tyrosine-Derived Inhibitors of Human Nonpancreatic Secretory Phospholipase A2 (2000) (0)
Specific for Riboflavin Metabolites Mucosal-Associated Invariant T Cells Antimycobacterial Effects of Mouse Functional Heterogeneity and (2015) (0)
NMR structure of a short hydrophobic 11mer peptide in DMSO-d6/H2O (1:3) solution (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David P. Fairlie?

David P. Fairlie is affiliated with the following schools:

David P. Fairlie's Academic­Influence.com Rankings

David P. Fairlie's Degrees

Similar Degrees You Can Earn

Why Is David P. Fairlie Influential?

David P. Fairlie's Published Works

Published Works

What Schools Are Affiliated With David P. Fairlie?

David P. Fairlie's AcademicInfluence.com Rankings